Vor Ort
Merkzettel Warenkorb
  • Produktbild: Advances in Dementia Research
  • Produktbild: Advances in Dementia Research
Band 59 - 10%

Advances in Dementia Research

Aus der Reihe Journal of Neural Transmission. Supplementa
10% sparen

197,99 € UVP 219,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

14.07.2000

Herausgeber

Kurt A. Jellinger + weitere

Verlag

Springer Wien

Seitenzahl

339

Maße (L/B/H)

27,9/21/2 cm

Gewicht

960 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-3-211-83512-8

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

14.07.2000

Herausgeber

Verlag

Springer Wien

Seitenzahl

339

Maße (L/B/H)

27,9/21/2 cm

Gewicht

960 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-3-211-83512-8

Herstelleradresse

Springer Wien
Prinz-Eugen-Str. 8-10
1040 Wien
AT
buchhandel-buch@springer.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Advances in Dementia Research
  • Produktbild: Advances in Dementia Research
  • White matter changes: the clinical consequences in the aging population.- Longitudinal change of white matter abnormalities.- Genetic aspects of microangiopathy-related cerebral damage.- Research criteria for subcortical vascular dementia in clinical trials.- How can cerebral infarcts and hemorrhages lead todementia?.- Vascular aspects in Alzheimer’s disease.- Novel imaging technologies in the assessment of cerebral ageing and vascular dementia.- Alzheimer disease and neuroinflammation.- The immunological microenvironment in the CNS: implications on neuronal cell death and survival.- Toxic effector molecules in the pathogenesis of immune-mediated disorders of the central nervous system.- Cytokines in CNS disorders: neurotoxicity versus neuroprotection.- Do neuronal inclusions kill the cell?.- Mechanisms of cell death in neurodegenerative disorders.- Estrogens, apoptosis and cells of neural origin.- Markers of apoptosis and models of programmed cell death in Alzheimer’s disease.- Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease.- Genetics of Alzheimer’s disease — routes to the pathophysiology.- Secretion of the amyloid precursor protein is elevated isoform specifically by apolipoprotein E4.- Alterations in neurotrophins and neurotrophin receptors in Alzheimer’s disease.- Genetically altered transgenic models of Alzheimer’s disease.- Morphological substrates of mental dysfunction in Lewy body disease: an update.- Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach.- Understanding the role of estrogen on cognition and dementia.- Present and future of Alzheimer therapy.- Trials to slow progression and prevent disease onset.- Epidemiologic clues to the causes and routes to prevention of Alzheimer disease.- Post-transcription modulation of the blood-brain barrier GLUT1 glucose transporter by brain-derived factors.- A brain derived peptide preparation reduces the translation dependent loss of a cytoskeletal protein in primary cultured chicken neurons.- Neurotrophic effects of Cerebrolysin® in animal models of excitotoxicity.- Cerebrolysin® reduces microglial activation in vivo and in vitro: a potential mechanism of neuroprotection.- Clinical experience with Cerebrolysin®.- Approach towards an integrative drug treatment of Alzheimer’s disease.- Oral Cerebrolysin® enhances brain alpha activity and improves cognitive performance in elderly control subjects.